People with Pharma/Biotech clinical trial experience/background/knowledge regarding FDA trials:
For eIND applications (Emergency Investigational New Drug) of prospective drugs, how typical is it for the FDA to provide guidance on an open-label extension for a prospective drug's Phase 3 trial and criteria for eINDs for doctors or hospitals treating patients meeting trial criteria? For example, small biotech Cytodyn's Leronlimab (potential brand Vyrologix):
For swinging day traders at Monday's open and potentially for the day, yet cognizant of the real possibility shorters continue slamming CYDY back down. Hence, the question seeking more general sector information from people with actual direct pharma/ biotech/ FDA knowledge possibly more relevant for investors vs day traders.CYDY is a buy, great swing trade opportunity.
Mr. Wonderful says "Grown Men will Weep" when the FEDS come in regulate BTC. LOL
right? Good luck with that.Mr. Wonderful says "Grown Men will Weep" when the FEDS come in regulate BTC. LOL
For swinging day traders at Monday's open and potentially for the day, yet cognizant of the real possibility shorters continue slamming CYDY back down. Hence, the question seeking more general sector information from people with actual direct pharma/ biotech/ FDA knowledge possibly more relevant for investors vs day traders.
Glad today's quick flips worked out for you.... I got in and out today 3 times for some nice wins.
Gold Telegraph tweet: The Treasury Department has published guidance clarifying an executive order U.S investors can NO LONGER invest in ETFs and index funds as well as subsidiaries of Chinese companies designated as owned or controlled by the Chinese military
Comic gold:
Apparently, Gold Telegraph, the original tweeter did not understand the initial November US Treasury executive order, is massively ill informed regarding today's related guidance, and is unaware western investment managers, pension administrators, and global indices including MSCI, S&P DJ, and FTSE Russell have already been acting to purge mainland companies the Office of Foreign Assets Control identified as being owned or >50% controlled by the mainland PLA.
However, it would be entertaining to learn which ETFs, index funds, etc managed by US-domiciled or other western managers or indices used by US companies or marketed in the US the clueless Gold Telegraph tweeter believes the PLA owns or controls? /s
Analyze the actual facts. Today's Treasury guidance is neither really new nor did the Gold Telegraph tweeter understand the actual facts. Simply, explanatory information after the Treasury acted in November in response to Central Government actions your link references.U.S. Investors Are Funding Malign PRC Companies on Major Indices - United States Department of State
Under Xi Jinping, the CCP has prioritized something called ‘military-civil fusion.’ … Chinese companies and researchers must… under penalty of law – share technology with the Chinese military. The goal is to ensure that the People’s Liberation Army has military dominance. And the PLA’s core...www.state.gov
I bought it today right before close. Plan to sell it Jan 6th right before the merger vote. If merger is approved, the Clover stock goes live Jan 8th.$ IPOC is ready for take off .......
With similar objectives, holdings, risk, volatility, and close returns, why buy the high front-end loaded ADNPX with markedly-higher annual fees and a shorter track record (2017) vs ARKK (est 2014) with no front-end and just 45% of ADNPX's annual fees?
CYDY is a buy, great swing trade opportunity.
Looks like CYDY is setting up for a nice pop next week.